Lycia Therapeutics raised $75 million in private equity offering
Lycia Therapeutics, a Delaware biotechnology corporation, completed a $75 million private equity offering under Regulation D Rule 506(b), with 16 investors…
$75Mequity
Company
SEC filing news and material events for Lycia Therapeutics, Inc., briefed from primary-source filings.
1 story
Lycia Therapeutics, a Delaware biotechnology corporation, completed a $75 million private equity offering under Regulation D Rule 506(b), with 16 investors…